IASLC Launches Beta Version of VIKTOR

Tobacco Control Impacts Everyone in Respiratory Medicine, JTO CRR Editor Says

Smoking Cessation in Lung Cancer Screening: The Latest Randomized Controlled Trial Evidence

… the US Veterans Health Administration (VA). 5 , 7  This research sought to determine the key components … the trials were conducted in 76 clinics with over 5,700 research participants nationwide.   SCALE Collaboration … support was delivered to clinical providers; of note, the research team did not intervene directly with patients. 20 …

IASLC Announces Partnerships to Spur Oncogene-Driven Lung Cancer Research, Address Global Challenges in Conquering Thoracic Cancers

Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award Lecture

… Dr. Hirsch’s significant contributions to international research and education. … Renowned Researcher Fred Hirsch Delivers 2022 Heine H. Hansen Award …

IASLC, LCRF Request Proposals for New Research Grant

Pathology Researcher Keith Kerr Receives 2025 Heine H. Hansen Award

Journal of Thoracic Oncology’s Impact Factor Rises Again; JTO Clinical and Research Reports Receives First Impact Factor

… Oncology’s Impact Factor Rises Again; JTO Clinical and Research Reports Receives First Impact Factor … Erin Jungmeyer …

Tobacco Control Committee Chair Discusses Recent Legislative, Research Developments

In Case You Missed It: IASLC Launches New Education Center

IASLC Launches Global Member Survey on Diversity, Equity, and Inclusion

Can pCR Be an Early Clinical Trial Endpoint? Initiative Aims to Answer That Question